Daewoong, 14.45% ↑ on Rising Theme of COVID-19 (Treatment/Vaccine Development)

On the 18th, the COVID-19 (treatment/vaccine development, etc.) theme rose by 3.11% compared to the previous day, showing strength, while Daewoong, a stock attracting attention as a related stock, surged by 14.45% compared to the previous day. Daewoong is known as a holding company specializing in investments related to healthcare and the bio industry.

[Graph] Major stock price changes in the COVID-19 (treatment/vaccine development, etc.) theme

According to provisional data compiled at 11:36, foreigners are net buying 31,900 shares of Daewoong.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Daewoong ranked 2nd in the quant financial ranking (out of 25 stocks) by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Daewoong having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.